AKT1 and medullary thyroid gland carcinoma: We consequently conducted a recent study and demonstrated that MTC-harboring RAS mutations showed a preferential activation of the PI3K/Akt/mTOR pathway, revealed by an intense phospho-Akt reactivity pattern on Western blot analysis [24].